Islets in type 2 diabetes: In honor of Dr. Robert C. Turner

Diabetes

Volumn 57, Issue 11, 2008, Pages 2899-2904

  Bonner Weir, Susan ^a   O'Brien, Timothy D ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; AMYLOID; FAS ANTIBODY; FAS LIGAND; FREE RADICAL; GLUCAGON; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; INSULIN; KI 67 ANTIGEN; PREALBUMIN; PRION PROTEIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; SYNUCLEIN;

APOPTOSIS; CELL COMPOSITION; CELL DENSITY; CELL DIVISION; CELL LOSS; CELL RENEWAL; CELL STRUCTURE; CELL VOLUME; CYTOTOXICITY; ENDOPLASMIC RETICULUM STRESS; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULINOMA; MORPHOMETRICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; ORGAN WEIGHT; OXIDATIVE STRESS; PANCREAS BIOPSY; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; AMYLOIDOSIS; ARTICLE; BLOOD; HISTORY; MEDICAL RESEARCH; METABOLISM; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PATHOLOGY; PATHOPHYSIOLOGY;

AMYLOID; AMYLOIDOSIS; BIOMEDICAL RESEARCH; DIABETES MELLITUS, TYPE 2; HISTORY, 20TH CENTURY; HUMANS; ISLETS OF LANGERHANS;

EID: 58149337276     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db07-1842     Document Type: Review

References (51)

1. Turner RC: The U.K. Prospective Diabetes Study: a review. Diabetes Care 21 (Suppl. 3):C35-C38, 1998
2. Orci L, Unger RH: Functional subdivision of islets of Langerhans and possible role of D-cells. Lancet 2:1243-1244, 1975
3. Erlandsen SL, Hegre OD, Parsons JA, McEvoy RC, Elde RP: Pancreatic islet cell hormones distribution of cell types in the islet and evidence for the presence of somatostatin and gastrin within the D cell. J Histo Cyto 24:883-897, 1976
4. Grube D, Eckert I, Speck PT, Wagner HJ: Immunohistochemistry and microanatomy of the islets of Langerhans. Biomed Res 4 (Suppl.):25-36, 1983
5. Cabrera O, Berman DM, Kenyon NS, Ricordi C, Berggren PO, Caicedo A: The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci USA 103:2334-2339, 2006
6. Brissova M, Fowler MJ, Nicholson WE, Chu A, Hirshberg B, Harlan DM, Powers AC: Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J Histochem Cyto-chem 53:1087-1097, 2005
7. Orci L: The microanatomy of the islets of Langerhans. Metabolism 25:1303-1313, 1976
8. Toreson WE: Glycogen infiltration (so-called hydropic degeneration) in the pancreas of human and experimental diabetes mellitus. Am, J Pathol 27:327-347, 1951
9. Gepts W, In't Veld PA: Islet Morphologic Changes. Diab Metab Rev 3:859-872, 1987
10. Stefan Y, Grasso S, Perrelet A, Orci L: The pancreatic polypeptide-rich lobe of the human pancreas: definitive identification of its derivation from the ventral pancreatic primordium. Diabetologia 23:141-142, 1982
11. Rahier J, Goebbels RM, Henquin JC: Cellular composition of the human diabetic pancreas. Diabetologia 24:366-371, 1983
12. Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S: Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients. Diabetologia 45:85-96, 2002
13. Kloppel G, Lohr M, Habich K, Oberholzer M, Heitz PU: Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res 4:110-125, 1985
14. Rahier J, Wallon J, Loozen S, Lefevre A, Gepts W, Haot J: The pancreatic polypeptide cells in the human pancreas: the effects of age and diabetes. J Clin Endocrinol Metab 56:441-444, 1983
15. Yoon KH, Ko SH, Cho JH, Lee JM, Ahn YB, Song KH, Yoo SJ, Kang MI, Cha BY, Lee KW, Son HY, Kang SK, Kim DG, Lee IK, Bonner-Weir S: Selective β-cell loss and a-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endoc Metab 88:2300-2308, 2003
16. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC: Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110, 2003
17. Maclean N, Ogilvie RF: Quantitative estimation of the pancreatic islet tissue in diabetic subjects. Diabetes 4:367-376, 1955
18. Saisho Y, Butler AE, Meier JJ, Monchamp T, Allen-Auerbach M, Rizza RA, Butler PC: Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat 20:933-942, 2007
19. Ogilvie RF: The islands of Langerhans in 19 cases of obesity. J Pathol Bacterol 37:473-481, 1933
20. Bonner-Weir S: Islet growth and development in the adult. J Mol Endocri-nol 24:297-302, 2000
21. Guiot Y, Sempoux C, Moulin P, Rahier J: No decrease of the beta-cell mass in type 2 diabetic patients (Abstract). Diabetes 50 (Suppl. 1):S188, 2001
22. Clark A, Jones LC, de Koning E, Hansen BC, Matthews DR: Decreased insulin secretion in type 2 diabetes: a problem of cellular mass or function? (Abstract). Diabetes 50 (Suppl. 1):S169-S171, 2001
23. Saito K, Yaginuma N, Takahashi T: Differential volumetry of A, B, and D cells in the pancreatic islets of diabetic and non-diabetic subjects. Tohoku J Exp Med 129:273-283, 1979
24. Jonas JC, Sharma A, Hasenkamp W, Ilkova H, Patane G, Laybutt R, Bonner-Weir S, Weir GC: Chronic hyperglycemia triggers loss ofpancreatic β cell differentiation in an animal model of diabetes. J Biol Chem 274:14112-14121, 1999
25. LeCompte PM, Merriam JC: Mitotic figures and enlarged nuclei in the islands of Langerhans in man. Diabetes 2:35-39, 1962
26. Lorenzo A, Razzaboni B, Weir GC, Yankner BA: Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 368: 756-760, 1994
27. Johnson KH, O'Brien TD, Westermark P: Medical intelligence: islet amyloid, islet amyloid polypeptide and diabetes mellitus. N Engl J Med 321:513-518, 1989
28. Westermark P, Wernstedt C, Heldin C-H, Wilander E, Hayden DW, O'Brien TD, Johnson KH: Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a novel neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 84:3881-3885, 1987
29. Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB, Reid KBM: Purification and characterization of a peptide from amyloid-rich pancreata of type 2 diabetic patients. Proc Natl Acad Sci USA84:8628-8632, 1987
30. Butler PC, Chou J, Carter WB, Wang YN, Bu BH, Chang D, Chang JK, Rizza RA: Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 39:752-756, 1990
31. Mirzabekov TA, Lin M-C, Kagan BL: Pore formation by the cytotoxic islet amyloid peptide amylin. J Biol Chem 271:1988-1992, 1996
32. Tucker HM, Rydel RE, Wright S, Estus S: Human amylin induces "apopto- tic" pattern of gene expression concomitant with cortical neuronal apo- ptosis. J Neurochem 71:506-516, 1998
33. Janson J, Ashley RH, Harrison D, McIntyre S, Butler PC: The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate- sized toxic amyloid particles. Diabetes 48:491-498, 1999
34. O'Brien TD, Butler PC, Kreutter DK, Kane LA, Eberhardt NL: Intracellular amyloid associated with cytotoxicity in COS-1 cells expressing human islet amyloid polypeptide. Am J Pathol 147:609 -616, 1995
35. Mattson MP, Goodman Y: Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium. Brain Res 676:219-224
36. Mark RJ, Pang Z, Geddes JW, Uchida K, Mattson MP: Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J Neurosci 17:1046-1054, 1997
37. Brender JR, Dürr UHN, Heyl D, Budarapu MB, Ramamoorthy A: Membrane fragmentation by an amyloidogenic fragment of human islet amyloid polypeptide detected by solid-state NMR spectroscopy of membrane nanotubes. Biochim Biophys Acta 1768:2026-2029, 2007
38. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG: Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486-489, 2003
39. Lin C-Y, Gurlo T, Kayed R, Butler AE, Haataja L, Glabe CG, Butler PC: Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellu- lar, and vaccination to induce anti-toxic oligomers antibodies does not prevent h-IAPP-induced β-cell apoptosis in h-IAPP transgenic mice. Diabetes 56:1324-1332, 2007
40. Zhang S, Liu J, Dragunow M, Cooper GJS: Fibrillogenic amylin evokes islet β-cell apoptosis through linked activation of a caspase cascade and JNK1. J Biol Chem 278:52810-52819, 2003
41. Zhang S, Liu H, Yu H, Cooper GJ: Fas-associated death receptor signaling evoked by human amylin in islet β-cells. Diabetes 57:348-356, 2008
42. Fehmann HC, Weber V, Goke R, Goke B, Arnold R: Co-secretion of amylin and insulin from isolated rat pancreas. FEBS Lett 262:279-281, 1990
43. O'Brien TD, Westermark P, Johnson KH: Islet amyloid polypeptide and insulin secretion from isolated perfused pancreas of fed, fasted, glucose- treated, and dexamethasone-treated rats. Diabetes 40:1701-1706, 1991
44. Couce M, Kane L, O'Brien TD, Kreutter D, Soeller W, Butler PC: Induction of insulin resistance in mice transgenic for human islet amyloid polypep- tide causes islet amyloidosis and beta cell dysfunction. Diabetes 45:1094-1101, 1996
45. Soeller WC, Janson J, Hart SE, Parker JC, Carty MD, Stevenson RW, Kreutter DK, Butler PC: Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide. Diabetes 47:743-750, 1998
46. Hull RL, Andrikopoulos S, Verchere CB, Vidal J, Wang F, Cop M, Prigeon RL, Kahn SE: Increased dietary fat promotes islet amyloid formation and β-cell secretory dysfunction in a transgenic mouse model of islet amyloid. Diabetes 52:372-379, 2003
47. Harding HP, Ron D: Endoplasmic reticulum stress and the development of diabetes: a review. Diabetes 51 (Suppl. 3):S455-S461, 2002
48. Huang C-J, Lin C-Y, Haataja L, Gurlo T, Butler AE, Rizza RA, Butler PC: High expression rates of human islet amyloid polypeptide induce endo- plasmic reticulum stress-mediated β-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes. Diabetes 56:2016-2027, 2007
49. Howard CF, Jr: Longitudinal studies on the development of diabetes in individual Macaca nigra. Diabetologia 29:301-306, 1986
50. Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S: Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431:805-810, 2004
51. Ritzel RA, Butler PC: Replication increases β-cell vulnerability to human islet amyloid polypeptide-induced apoptosis. Diabetes 52:1701-1708, 2003